Literature DB >> 2344860

Effects of adinazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

M Linnoila1, J M Stapleton, R Lister, H Moss, E Lane, A Granger, D J Greenblatt, M J Eckardt.   

Abstract

Effects on psychomotor and cognitive performance of adinazolam (15 or 30 mg), alone and in combination with ethanol (0.8 g/kg), were studied in healthy male volunteers and compared to effects of 10 mg diazepam. Adinazolam 30 mg produced relatively long-lasting impairments on tests of tracking, attention, verbal and nonverbal information processing, and memory. Adinazolam 15 mg resulted in descreased visual information processing. Adinazolam decreased supine mean arterial pressure, but only the 15 mg resulted in a tendency for decreased plasma norepinephrine concentrations. After standing for 5 min, 30 mg adinazolam was associated with increased heart rate. Although ethanol consumption produced additive decrements on a continuous performance task, there was little evidence to support a synergistic effect. Adinazolam 30 mg was accompanied by increased self-reports of side effects, especially drowsiness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344860     DOI: 10.1007/bf00315578

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  30 in total

1.  Diazepam actions and plasma concentrations following ethanol ingestion.

Authors:  S M MacLeod; H G Giles; G Patzalek; J J Thiessen; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

2.  SCL-90: an outpatient psychiatric rating scale--preliminary report.

Authors:  L R Derogatis; R S Lipman; L Covi
Journal:  Psychopharmacol Bull       Date:  1973-01

3.  A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.

Authors:  J P Feighner
Journal:  Psychopharmacol Bull       Date:  1986

4.  Second-generation antidepressants.

Authors:  L E Hollister
Journal:  Ration Drug Ther       Date:  1982-12

5.  Suppression of norepinephrine appearance rate in plasma by diazepam in humans.

Authors:  P P Roy-Byrne; N Lewis; E Villacres; D J Greenblatt; R I Shader; R C Veith
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

6.  Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients.

Authors:  W T Smith; V Glaudin
Journal:  Acta Psychiatr Scand       Date:  1986-09       Impact factor: 6.392

7.  Effect of alcohol consumption on state anxiety changes in male and female nonalcoholics.

Authors:  P E Logue; W D Gentry; M Linnoila; C W Erwin
Journal:  Am J Psychiatry       Date:  1978-09       Impact factor: 18.112

8.  Effects of antidepressants on skilled performance.

Authors:  M Linnoila; J Johnson; K Dubyoski; M S Buchsbaum; M Schneinin; C Kilts
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.

Authors:  R G Lister; S E File
Journal:  J Clin Psychopharmacol       Date:  1983-04       Impact factor: 3.153

10.  Kinetic and dynamic interaction of brotizolam and ethanol.

Authors:  J M Scavone; D J Greenblatt; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

View more
  5 in total

1.  Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Authors:  Viera Lukacova; Walter S Woltosz; Michael B Bolger
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

2.  Reinforcing effectiveness of midazolam, ethanol, and sucrose: behavioral economic comparison of a mixture relative to its component solutions.

Authors:  E Andrew Townsend; Donna M Platt; James K Rowlett; Peter G Roma; Kevin B Freeman
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

Review 3.  Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation.

Authors:  S D Ferrara; S Zancaner; R Giorgetti
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

Review 4.  Alcohol and vigilance performance: a review.

Authors:  H S Koelega
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

5.  Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.

Authors:  Benjamin Berger; Sander Brooks; Rob Zuiker; Muriel Richard; Clemens Muehlan; Jasper Dingemanse
Journal:  CNS Drugs       Date:  2020-11-18       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.